Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer now displays website revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T08:09:59.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry for v3.7.0 and the previous revision v3.6.6 is removed from the history.
    Difference
    0.1%
    Check dated 2026-09-20T02:39:26.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The history log now includes a new revision label v3.6.6, replacing the previous v3.6.5. This reflects an update to the page's revision in the study record history.
    Difference
    0.1%
    Check dated 2026-08-29T19:50:19.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    A new page revision label 'Revision: v3.6.5' is added to the history, replacing the previous 'Revision: v3.6.4'. This indicates a minor frontend update to the record page without changes to study data or results.
    Difference
    0.2%
    Check dated 2026-08-08T16:48:23.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A new revision (v3.6.4) was added to the study record history, and the previous revision (v3.6.3) was removed from the list, reflecting an update to the record's version history.
    Difference
    0.1%
    Check dated 2026-07-25T08:29:46.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The record history now includes a newer revision (v3.6.3) replacing the previous revision (v3.6.2), indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-07-03T22:00:13.000Z thumbnail image

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.